BC is divided into four main categories according to whether tumor-expressing factors such as HR and HER2 are present or absent: luminal A (HR+/HER2-), luminal B (HR+/HER2+), HER2 positive (HR-/HER2+), and triple-negative (HR-/HER2-) [45]. This evidence concerns the gene ERBB2 and breast cancer.